用于癌症治疗的基于原药的双特异性抗体:进展和未来方向
Zhijuan Ai1,2, Bing Wang3, Yunlong Song4
1The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
Frontiers in immunology
|February 6, 2025
概括
基于原药的双特异性抗体通过更精确地向瘤来增强癌症治疗. 本综述探讨了它们的激活机制和开发挑战,以改善临床使用.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 药物开发 药物开发
背景情况:
- 双特异性抗体在癌症治疗中比单克隆抗体具有更广泛的治疗潜力.
- 基于原药的双特异性抗体正在开发中,以改善瘤选择性和减少非标效应.
- 针对性的药物输送对于提高癌症治疗的疗效和最大限度地减少毒性至关重要.
研究的目的:
- 审查基于前药物的双特异性抗体的作用机制.
- 确定这些新型治疗方法的开发和临床应用中的挑战.
- 提供关于向癌症免疫治疗的未来的见解.
主要方法:
- 基于前药物的双特异抗体机制的文献综述.
- 激活途径的分析,包括蛋白酶介导,固体障碍释放,可溶性因子激活,条件组合和链交换.
- 讨论当前的挑战和该领域的未来方向.
主要成果:
- 基于原药的双特异性抗体利用了针对癌症治疗的多种激活策略.
- 机制包括蛋白酶介导激活,固体阻碍释放,可溶性因子激活,条件组合和链交换.
- 这些药物的优化需要解决特定的开发和临床应用挑战.
结论:
- 基于原药的双特异性抗体代表了向癌症治疗的有希望的进展.
- 了解它们的激活机制是克服发展障碍的关键.
- 需要进一步的研究才能充分实现这些复杂的药物的临床潜力.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464


